ArticleEuropean journal of haematology2020

Treatment with brentuximab vedotin plus bendamustine in unselected patients with CD30-positive aggressive lymphomas.

Sandro M Wagner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.